Intensity Therapeutics, Inc. (INTS)
NASDAQ: INTS · Real-Time Price · USD
2.500
-0.140 (-5.30%)
At close: Nov 19, 2026, 4:00 PM EST
2.510
+0.010 (0.40%)
After-hours: Nov 19, 2026, 4:10 PM EST
Intensity Therapeutics Market Cap
Intensity Therapeutics has a market cap or net worth of $8.25 million as of November 19, 2026. It is the 42,227th most valuable company in the world and the 5,595th biggest in the United States. Its market cap has decreased by 68.05% in one year.
Market Cap
8.25M
Enterprise Value
-154.06K
1-Year Change
-68.05%
Global Rank
Country Rank
#5,595 United States
Category
ChartMarket Cap Chart
Since the IPO on June 30, 2023, Intensity Therapeutics's market cap has decreased from $66.01M to $8.25M, a decrease of -87.50%. That is a compound annual growth rate of -45.83%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2026 | 8.25M | -66.50% |
| Dec 31, 2025 | 24.64M | -7.32% |
| Dec 31, 2024 | 26.58M | -77.37% |
| Dec 29, 2023 | 117.49M | 77.98% |
| Jun 30, 2023 | 66.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CytoMed Therapeutics | 9.35M |
| Cellectar Biosciences | 9.24M |
| BioLineRx | 9.21M |
| IN8bio | 8.86M |
| Lexaria Bioscience | 8.81M |
| Radiopharm Theranostics | 8.78M |
| Phio Pharmaceuticals | 8.57M |
| Aligos Therapeutics | 8.50M |